How should unknown amino acids be represented in a sequence listing?

The MPEP 2412.05(d) provides guidance on representing unknown amino acids in sequence listings: Use the symbol ‘X’ to represent unknown amino acids Provide further description in a feature table Use the feature key “UNSURE” and optionally the qualifier “note” The MPEP states, “Any “unknown” amino acid must be represented by the symbol “X” in the…

Read More

How are modified amino acids represented in sequence listings?

Modified amino acids in sequence listings are represented according to specific guidelines outlined in MPEP 2412.05(d): Modified amino acids should be represented as the corresponding unmodified amino acid in the sequence itself whenever possible. The modified amino acid must be further described in the Feature section of the sequence listing. As stated in the MPEP,…

Read More

How are modified amino acids represented in a sequence listing?

According to MPEP 2412.05(d), modified amino acids should be represented as follows: Represent as the corresponding unmodified amino acid when possible Use ‘X’ for modified amino acids that cannot be represented by other symbols Provide further description in a feature table The MPEP states, “WIPO Standard ST.26, paragraph 29, specifies that modified amino acids, including…

Read More

How should regions of contiguous ‘X’ residues be described in an amino acid sequence?

The MPEP 2412.05(d) provides guidance on describing regions of contiguous ‘X’ residues in amino acid sequences: Use the syntax “x..y” as the location descriptor Apply this for regions with a known number of contiguous ‘X’ residues Use this approach when the same description applies to all ‘X’ residues in the region The MPEP states, “WIPO…

Read More